Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › IL › Bloomington › NPI 1942268271

Boe, Erik

Boe, Erik was paid $453K by Medicaid between Jan 2018 and Dec 2024, across 20 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 48% of everything it billed.

33Billing provider infoBOE, ERIK
BLOOMINGTON, IL 61701
33aNPI1942268271assigned 05/03/2006
33bProvider typeSpecialist
28Total paid$453K
24GClaims7,875
24DCodes billed20
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Specialist providers in Illinois

Rank by total paid#21 of 273
Median peer was paid$32K
This provider vs. median14×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$5.0K$10K$15K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20181,214$53K
20191,094$55K
2020971$51K
20211,420$82K
20221,073$71K
20231,124$72K
2024incomplete979$68K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 48% 2,876 2,454 $217K
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 11% 1,057 930 $48K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 6.6% 399 361 $30K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 5.6% 322 201 $25K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 5.2% 177 167 $24K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 4.9% 290 256 $22K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 4.1% 227 211 $19K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 3.7% 378 359 $17K
96110 Developmental screening, with scoring and documentation, per standardized instrument 3.7% 886 820 $17K
96127 2.3% 465 407 $10K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 1.5% 98 89 $7K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 1.4% 123 111 $6K
8 more codes
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 1.3% 83 $6K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 71 $2K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 113 $2K
87081 <1% 59 $577.16
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 18 $563.40
0071A <1% 14 $560.00
91307 <1% 15 $0.02
99072 0% 204 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.